Literature DB >> 10669642

Leptin, peroxisome proliferator-activated receptor-gamma, and CCAAT/enhancer binding protein-alpha mRNA expression in adipose tissue of humans and their relation to cardiovascular risk factors.

F Krempler1, D Breban, H Oberkofler, H Esterbauer, E Hell, B Paulweber, W Patsch.   

Abstract

Obesity is a prevalent disorder that increases the risk for premature cardiovascular disease. The adipose tissue itself plays an active role in the regulation of fuel metabolism and energy homeostasis by expressing a number of regulatory genes, such as leptin, peroxisome proliferator-activated receptor-gamma (PPARgamma), and CCAAT/enhancer binding protein-alpha (C/EBPalpha). To study the in vivo relationships among these genes and their associations with cardiovascular risk factors, plasma levels of leptin, lipids, apolipoproteins (apo), insulin, and glucose were measured in 216 obese, 165 nonobese, and 36 weight-losing postobese subjects. mRNA expression of leptin, PPARgamma, and C/EBPalpha in the extraperitoneal and intraperitoneal adipose tissue was quantified in subsets of subjects. In obese individuals, plasma leptin was associated with apoA-I (r=0.2346, P<0.001) and insulin (r=0.2125, P<0.002). Leptin and C/EBPalpha mRNA expression in extraperitoneal and intraperitoneal adipose tissue of obese patients was higher than in the respective tissues of nonobese or postobese subjects. No significant differences among the study groups were found for PPARgamma mRNA expression. Leptin, PPARgamma, and C/EBPalpha mRNA levels correlated with each other in the intraperitoneal and extraperitoneal fat of obese subjects, but multivariate analysis revealed that only C/EBPalpha was a predictor of leptin expression in extraperitoneal tissue (partial r=0.6096, P<0.001). Intraperitoneal PPARgamma expression was inversely related to fasting insulin (r=-0.2888, P<0.017) and a fasting insulin resistance index (r=-0.2814, P<0.021) in obese subjects. In postobese patients, intraperitoneal PPARgamma expression was associated with plasma HDL cholesterol (r=0.5695, P<0.018) and apoA-I (r=0.6216, P<0.008) but was inversely related to LDL cholesterol (r=-0.5101, P<0.03) and apoB (r=-0.6331, P<0.007). These findings suggest a relationship between plasma leptin and HDL metabolism as well as adipose-tissue site-dependent associations among leptin, C/EBP-alpha, and PPAR-gamma mRNA expression. Furthermore, our results suggest that C/EBP-alpha enhances leptin expression in vivo and that PPARgamma mRNA expression is inversely associated with cardiovascular risk factors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10669642     DOI: 10.1161/01.atv.20.2.443

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  26 in total

Review 1.  Metabolic impact of body fat distribution.

Authors:  C Gasteyger; A Tremblay
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

2.  Distinct gene expression profile of human mesenchymal stem cells in comparison to skin fibroblasts employing cDNA microarray analysis of 9600 genes.

Authors:  Cornelia Brendel; Larissa Kuklick; Oliver Hartmann; Theo Daniel Kim; Ulrich Boudriot; Dagmar Schwell; Andreas Neubauer
Journal:  Gene Expr       Date:  2005

3.  Endoplasmic reticulum stress-induced CHOP activation mediates the down-regulation of leptin in human neuroblastoma SH-SY5Y cells treated with the oxysterol 27-hydroxycholesterol.

Authors:  Gurdeep Marwarha; Bhanu Dasari; Othman Ghribi
Journal:  Cell Signal       Date:  2011-10-01       Impact factor: 4.315

Review 4.  The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity.

Authors:  Frederick S Vom Saal; Susan C Nagel; Benjamin L Coe; Brittany M Angle; Julia A Taylor
Journal:  Mol Cell Endocrinol       Date:  2012-01-10       Impact factor: 4.102

5.  Effect of small doses of dexamethasone on plasma leptin levels in normal and obese subjects: a dose-response study.

Authors:  P Putignano; A Brunani; A Dubini; M Bertolini; R Pasquali; F Cavagnini
Journal:  J Endocrinol Invest       Date:  2003-02       Impact factor: 4.256

6.  APOA2, dietary fat, and body mass index: replication of a gene-diet interaction in 3 independent populations.

Authors:  Dolores Corella; Gina Peloso; Donna K Arnett; Serkalem Demissie; L Adrienne Cupples; Katherine Tucker; Chao-Qiang Lai; Laurence D Parnell; Oscar Coltell; Yu-Chi Lee; Jose M Ordovas
Journal:  Arch Intern Med       Date:  2009-11-09

7.  Soy pinitol acts partly as an insulin sensitizer or insulin mediator in 3T3-L1 preadipocytes.

Authors:  Gyeong-Min Do; Myung-Sook Choi; Hye-Jin Kim; Myung-Nam Woo; Mi-Kyung Lee; Seon-Min Jeon
Journal:  Genes Nutr       Date:  2008-02       Impact factor: 5.523

8.  Regulation of ATGL expression mediated by leptin in vitro in porcine adipocyte lipolysis.

Authors:  Yu-cheng Li; Xue-li Zheng; Bing-ting Liu; Gong-she Yang
Journal:  Mol Cell Biochem       Date:  2009-07-22       Impact factor: 3.396

Review 9.  Biomarkers of obesity and subsequent cardiovascular events.

Authors:  Salma Musaad; Erin N Haynes
Journal:  Epidemiol Rev       Date:  2007-05-10       Impact factor: 6.222

10.  Adipose tissue distribution and quantification of PPARbeta/delta and PPARgamma1-3 mRNAs: discordant gene expression in subcutaneous, retroperitoneal and visceral adipose tissue of morbidly obese patients.

Authors:  Josiane Woutheres Bortolotto; Rogério Margis; Angela Cristine Bersch Ferreira; Alexandre Vontobel Padoin; Cláudio Cora Mottin; Regina Maria Guaragna
Journal:  Obes Surg       Date:  2007-07       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.